Verona Pharma Plc ADR (VRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRNA | CYTK | HALO | ||
| Company | Verona Pharma Plc ADR | Cytokinetics | Halozyme Therapeutic | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 106.85 | 72.85 | 71.72 | ||
| High | 106.93 | 73.47 | 72.25 | ||
| Low | 106.81 | 70.58 | 70.71 | ||
| Latest | 106.91 | 71.48 | 71.53 | ||
| Change | +0.12 | -0.81 | -0.07 | ||
| % Change | +0.11% | -1.12% | -0.10% | ||
| Volume | 1,871,900 | 1,600,760 | 1,144,088 | ||
| 20-Day Average Volume | 1,504,320 | 2,206,523 | 2,065,250 | ||
| Previous Close | 106.79 | 72.29 | 71.60 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 106.48 | 75.47 | 68.46 | ||
| 20-Day Raw Stochastic | 98.26% | 14.64% | 77.29% | ||
| 20-Day Relative Strength | 70.52 | 49.65 | 58.60 | ||
| Weighted Alpha | +201.62 | +65.29 | +26.53 | ||
| Today's Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 88% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.28% since 09/29/25 | -6.88% since 05/29/26 | +7.50% since 05/29/26 | ||
| Low | 106.61 on 09/30/25 | 70.17 on 06/03/26 | 65.60 on 06/02/26 | ||
| High | 106.93 on 10/06/25 | 76.48 on 06/01/26 | 72.25 on 06/05/26 | ||
| 1-Month | |||||
| %Chg | +0.56% since 09/05/25 | -7.28% since 05/05/26 | +8.59% since 05/05/26 | ||
| Low | 105.78 on 09/19/25 | 70.17 on 06/03/26 | 63.50 on 05/11/26 | ||
| High | 106.93 on 10/06/25 | 79.12 on 05/20/26 | 73.89 on 05/12/26 | ||
| 3-Month | |||||
| %Chg | +16.80% since 07/03/25 | +14.94% since 03/05/26 | +6.19% since 03/05/26 | ||
| Low | 86.63 on 07/08/25 | 58.43 on 03/13/26 | 61.33 on 03/27/26 | ||
| High | 106.93 on 10/06/25 | 80.20 on 05/05/26 | 73.89 on 05/12/26 | ||
| 6-Month | |||||
| %Chg | +98.35% since 04/04/25 | +8.85% since 12/05/25 | +12.95% since 12/05/25 | ||
| Low | 47.20 on 04/07/25 | 58.43 on 03/13/26 | 61.22 on 12/11/25 | ||
| High | 106.93 on 10/06/25 | 80.20 on 05/05/26 | 82.22 on 02/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,748,446 | 8,995,261 | 8,492,690 | ||
| Shares Outstanding, K | 81,830 | 124,433 | 118,613 | ||
| Annual Sales | 42,280,000 | 88,040,000 | 1,396,610,000 | ||
| Annual Net Income | -173,420,000 | -784,960,000 | 316,890,000 | ||
| Last Quarter Sales | 103,140,000 | 19,360,000 | 376,710,000 | ||
| Last Quarter Net Income | 11,920,000 | -206,030,000 | 150,050,000 | ||
| 60-Month Beta | 0.05 | 0.42 | 0.88 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.13 on 08/06/25 | -1.67 on 05/05/26 | 1.60 on 05/11/26 | ||
| Earnings Date | 11/03/25 | 08/06/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 16.51 | ||